Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03970746
Title Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors PDC*line Pharma SAS

lung adenocarcinoma

lung non-small cell carcinoma

lung squamous cell carcinoma


PDC*lung01 + Pembrolizumab

PDC*lung01 + Pemetrexed Disodium


Age Groups: senior | adult
Covered Countries FRA | DEU | BEL

Additional content available in CKB BOOST